Newswise — David C. Hohn, MD, President and CEO of Roswell Park Comprehensive Cancer Center from 1997-2007, died Oct. 30 at age 84. “He really saved this place,” says Roswell Park President and CEO Candace S. Johnson, PhD. “It was his leadership that turned…
Adelaide University researchers have found a DNA 'switch' that helps the body stop the growth of the most common form of breast cancer, providing new insights that could help with future treatments. Up to 80% of breast cancer cases are classified…
First approved by the FDA in February 2004, cetuximab became an important targeted therapy for metastatic colorectal cancer (mCRC) and squamous cell carcinoma of the head and neck (SCCHN). Its efficacy in colorectal cancer is strongly influenced by molecular characteristics, particularly…
Gulf Daily News (Bahrain) North Korea says EU should ’mind its own business’ on human rights, KCNA reports Thu, 05 Nov 2026 Trump loses his grip on courts with poll debacle Trump admits Iran war’s role in midterm poll loss Death toll…
Small cell lung cancer (SCLC) responds quickly to treatment and relapses just as quickly. Everything in its management, from the first work-up to the follow-up schedule, is shaped by that tension. The 2026 Algerian National Therapeutic Guidelines in Medical Oncology give…
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. Two WashU Medicine investigators who are research members at Siteman Cancer Center, based at Barnes-Jewish…
Inside the Non-Small Cell Lung Cancer Immunotherapy Conversations Shaping Pharmacy Practice Pharmacy Times Inside the Non-Small Cell Lung Cancer Immunotherapy Conversations Shaping Pharmacy Practice Clinical pharmacy specialists in thoracic oncology discuss how frontline immunotherapy regimens are chosen in non-small cell…
| Newswise Newswise Precision Oncology: The âGenetic Mapâ of Patientâs Tumor Uncovers Cancer Risk Genes That Would Otherwise Remain Hidden These are the findings of an ongoing clinical study at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS. One in…
Cerenome Secures National In-Network Agreement with Aetna for CNSide® BuzzFeed, Inc. Reports Q3 2026 Financial Results HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia GOLD ROYALTY REPORTS RECORD THREE AND NINE-MONTH RESULTS WITH CONTINUED STRONG CASH FLOW…
From 1 December 2026, Singapore Citizens and PRs can get means-tested subsidies of up to 70% on genetic testing for hereditary breast and ovarian cancer (HBOC) at three public cancer clinics. MOH says the roughly $1,000 test can cost $0 out of pocket with enough…
Cancer prevention, screening, therapies, survivorship, and blood disorders.
An article joins this feed when it matches these terms. Each one is also a search of its own.